Validation of the "World Health Organization Disability Assessment Schedule, WHODAS-2" in patients with chronic diseases
Olatz Garín(Universitat Pompeu Fabra), Montse Ferrer(Universitat Pompeu Fabra), Somnath Chatterji(World Health Organization), Alberto Raggi(Fondazione IRCCS Istituto Neurologico Carlo Besta), Vittorio Racca(Don Carlo Gnocchi Foundation), Marta Nieto‐Moreno(Centro de Investigación Biomédica en Red de Salud Mental), Carlo Francescutti(Agenzia Regionale di Sanità della Toscana), Nenad Kostanjsek(World Health Organization), Josué Almansa(Hospital Del Mar), Matilde Leonardi(Fondazione IRCCS Istituto Neurologico Carlo Besta), Olga Svetskova(Charles University), Helena Burger(Univerzitetni Rehabilitacijski Inštitut), Eduard Vieta(Hospital Clínic de Barcelona), José Luís Ayuso‐Mateos(Universidad Autónoma de Madrid), Alarcos Cieza(World Health Organization - Pakistan), Gemma Vilagut(Instituto de Salud Carlos III), Jordi Alonso(World Federation for Mental Health)
Cited by 439
Related Papers
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.1k
The size and burden of mental disorders and other disorders of the brain in Europe 2010
|European Neuropsychopharmacology|2011|3.8k
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
Cost of disorders of the brain in Europe 2010
|European Neuropsychopharmacology|2011|1.7k